Early feasibility study results are promising for AltaValve, which is designed with a novel atrial fixation system to ...
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve ...
MedPage Today on MSN
BATMAN technique promising in transcatheter mitral valve replacement
Leaflet modification technique developed to prevent LVOT obstruction ...
It remains early days for transcatheter mitral-valve replacement (TMVR) as a minimally invasive way to treat severe, mitral regurgitation (MR), but it's even earlier days for TMVR as an endovascular ...
Edwards Lifesciences’ SAPIEN M3 mitral valve replacement system has become the first transcatheter therapy utilizing a transseptal approach to snag FDA approval in the U.S. for the treatment of mitral ...
After snaring the U.S. FDA’s approval for the Evoque tricuspid valve device, Edwards Lifesciences Corp. petitioned the Centers for Medicare & Medicaid Services for a national coverage determination ...
(RTTNews) - Edwards Lifesciences (EW) said it has exercised its option to acquire Innovalve Bio Medical, an early-stage transcatheter mitral valve replacement company, following its initial investment ...
Edwards Lifesciences recently announced that it would acquire Innovalve Bio Medical, an early-stage transcatheter mitral valve replacement (“TMVR”) company. Edwards had the option to acquire Innovalve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results